Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,13 USD | +1,00% | -3,74% | -17,44% |
Omzet 2024 * | 33,61 mln. 31,41 mln. | Omzet 2025 * | 45,96 mln. 42,96 mln. | Marktkapitalisatie | 59,3 mln. 55,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -47 mln. -43,93 mln. | Nettowinst (verlies) 2025 * | -68 mln. -63,56 mln. | EV/omzet 2024 * | 1,76 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,29 x |
K/w-verhouding 2024 * |
-1,64
x | K/w-verhouding 2025 * |
-1,05
x | Werknemers | 69 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,66% |
Recentste transcriptie over Cidara Therapeutics, Inc.
1 dag | +1,00% | ||
1 week | -3,74% | ||
Lopende maand | -28,75% | ||
1 maand | -11,42% | ||
3 maanden | -1,41% | ||
6 maanden | -18,92% | ||
Lopend jaar | -17,44% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 01-01-14 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 01-09-21 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 01-01-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 01-04-14 |
Director/Board Member | 69 | 01-04-14 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 01-01-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 13,14 | +1,08% | 163 374 |
25-04-24 | 13 | +5,78% | 753 807 |
24-04-24 | 12,29 | +19,90% | 326 436 |
23-04-24 | 10,25 | -0,27% | 96 083 |
22-04-24 | 10,28 | -24,54% | 192 657 |
uitgestelde koers Nasdaq, 26 april 2024 om 20:35 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-17,44% | 59,3 mln. | |
-2,16% | 103 mld. | |
+0,63% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,09% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,94% | 15,52 mld. | |
+3,46% | 13,86 mld. | |
+34,43% | 12,04 mld. |